Following approval by CRG, the July meetings of GMMMG and the Greater Manchester ICS Clinical Effectiveness and Governance Committee, the following updates have been made to GMMMG guidelines, formulary, and RAG list:
- Tezepelmuab for treating severe asthma added to formulary as RED
- Fosofomycin for uncomplicated UTI updated to GREEN RAG status
- Greater Manchester Hypertension Medication pathway published, alongside supporting information and a medication table
- Greater Manchester Antimicrobial guidelines updated
- Ustekinumab dose-escalation in Crohn’s and ulcerative colitis – statement updated
The formulary has also been updated to reflect relevant safety alerts and NICE guidelines. For full details, see the GMMMG decision summary for August 2023, or the formulary change log available on the formulary page.